Business Context and Reporting Period
Company: BioLife Solutions, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 3, 2026
Event: Regulation FD Disclosure regarding the issuance of an investor presentation.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the availability of an investor presentation and does not contain audited or unaudited financial statements.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing is procedural, intended to make an investor presentation available to the public in compliance with Regulation FD.
Guidance, Outlook, and Management Commentary
- Investor Presentation: The Company issued an investor presentation on June 3, 2026, which is attached as Exhibit 99.1.
- Usage: Management intends to use this presentation at the Jefferies Global Healthcare Conference and other investor meetings.
- Legal Status: The information in the presentation is "furnished" and not "filed" under the Securities Exchange Act of 1934. It is not subject to Section 18 liabilities and is not incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Review Exhibit 99.1 (Investor Presentation) for actual financial data, guidance, and strategic updates.
- Verify the presentation content on the Company's investor relations website at https://investors.biolifesolutions.com/investor_presentation.
- Note that the presentation content is not legally "filed" with the SEC for liability purposes under Section 18 of the Exchange Act.